Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.
Wolf AS, Bjørlykke KH, Ørbo HS, Bhandari S, Solum G, Kjønstad IF, Jyssum I, Nygaard UC, Kristoffersen AB, Christensen IE, Josefsson SE, Lund KP, Chopra A, Osen JR, Chaban V, Tveter AT, Sexton J, Kvien TK, Jahnsen J, Haavardsholm EA, Grødeland G, Vaage JT, Provan SA, Kared H, Lund-Johansen F, Munthe LA, Syversen SW, Goll GL, Jørgensen KK, Mjaaland S. Wolf AS, et al. Among authors: lund johansen f. EBioMedicine. 2024 Oct;108:105317. doi: 10.1016/j.ebiom.2024.105317. Epub 2024 Sep 10. EBioMedicine. 2024. PMID: 39260039 Free PMC article.
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants.
Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K, Thomassen KS, Kro GB, Cox RJ, Zhou F, Langeland N, Aukrust P, Melum E, Åvitsland TL, Wiencke K, Holter JC, Munthe LA, Grødeland G, Andersen JT, Vaage JT, Lund-Johansen F. Tran TT, et al. NPJ Vaccines. 2022 Dec 30;7(1):174. doi: 10.1038/s41541-022-00586-7. NPJ Vaccines. 2022. PMID: 36585405 Free PMC article.
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants.
Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K, Thomassen KS, Kro GB, Cox RJ, Zhou F, Langeland N, Aukrust P, Melum E, Åvitsland TL, Wiencke K, Holter JC, Munthe LA, Grødeland G, Andersen JT, Vaage JT, Lund-Johansen F. Tran TT, et al. NPJ Vaccines. 2023 Jan 25;8(1):4. doi: 10.1038/s41541-023-00600-6. NPJ Vaccines. 2023. PMID: 36697432 Free PMC article. No abstract available.
Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study.
Ravussin A, Robertson AH, Wolf AS, Blix K, Kjønstad IF, Solum G, Feiring B, Strand BH, Lund-Johansen F, Munthe LA, Magnus P, Trogstad L, Mjaaland S. Ravussin A, et al. Lancet Healthy Longev. 2023 May;4(5):e188-e199. doi: 10.1016/S2666-7568(23)00055-7. Lancet Healthy Longev. 2023. PMID: 37148891 Free PMC article.
T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis.
Wolf AS, Ravussin A, König M, Øverås MH, Solum G, Kjønstad IF, Chopra A, Holmøy T, Harbo HF, Syversen SW, Jørgensen KK, Høgestøl EA, Vaage JT, Celius EG, Lund-Johansen F, Munthe LA, Nygaard GO, Mjaaland S. Wolf AS, et al. JCI Insight. 2023 Jun 22;8(12):e165111. doi: 10.1172/jci.insight.165111. JCI Insight. 2023. PMID: 37159281 Free PMC article.
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study.
Federico L, Tvedt THA, Gainullin M, Osen JR, Chaban V, Lund KP, Tietze L, Tran TT, Lund-Johansen F, Kared H, Lind A, Vaage JT, Stratford R, Tennøe S, Malone B, Clancy T, Myhre AEL, Gedde-Dahl T, Munthe LA. Federico L, et al. Front Immunol. 2023 Jul 7;14:1210899. doi: 10.3389/fimmu.2023.1210899. eCollection 2023. Front Immunol. 2023. PMID: 37503339 Free PMC article.
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients.
Kared H, Alirezaylavasani A, Lund KP, Chopra A, Tietze L, de Matos Kasahara T, Goll GL, Grødeland G, Kaarbø M, Reisæter AV, Hovd M, Heldal K, Vaage JT, Lund-Johansen F, Midtvedt K, Åsberg A, Munthe LA. Kared H, et al. EBioMedicine. 2023 Nov;97:104833. doi: 10.1016/j.ebiom.2023.104833. Epub 2023 Oct 14. EBioMedicine. 2023. PMID: 37844534 Free PMC article.
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination.
Gainullin M, Federico L, Røkke Osen J, Chaban V, Kared H, Alirezaylavasani A, Lund-Johansen F, Wildendahl G, Jacobsen JA, Sarwar Anjum H, Stratford R, Tennøe S, Malone B, Clancy T, Vaage JT, Henriksen K, Wüsthoff L, Munthe LA. Gainullin M, et al. Among authors: lund johansen f. Front Immunol. 2024 Jan 17;14:1235210. doi: 10.3389/fimmu.2023.1235210. eCollection 2023. Front Immunol. 2024. PMID: 38299149 Free PMC article.
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.
Kared H, Jyssum I, Alirezaylavasani A, Egner IM, The Tran T, Tietze L, Lund KP, Tveter AT, Provan SA, Ørbo H, Haavardsholm EA, Vaage JT, Jørgensen K, Syversen SW, Lund-Johansen F, Goll GL, Munthe LA. Kared H, et al. Among authors: lund johansen f. Front Immunol. 2024 Feb 22;15:1296273. doi: 10.3389/fimmu.2024.1296273. eCollection 2024. Front Immunol. 2024. PMID: 38455062 Free PMC article.
127 results